ArticleFrontiers in neurology2022

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.

Cecilia Smith Simonsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.